Dimensional Fund Advisors
THRD

Dimensional Fund Advisors’s Third Harmonic Bio THRD Stock Holding History

Dimensional Fund Advisors’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-93,939
Closed -$505K – 3322
2025
Q3 		$505K Hold
93,939
– – ﹤0.01% 2994
2025
Q2 		$510K Hold
93,939
– – ﹤0.01% 2989
2025
Q1 		$326K Buy
93,939
+22,684
+32% +$110K ﹤0.01% 3062
2024
Q4 		$733K Buy
71,255
+44,389
+165% +$553K ﹤0.01% 2976
2024
Q3 		$364K Buy
26,866
+12,398
+86% +$154K ﹤0.01% 3086
2024
Q2 		$188K Buy
+14,468
New +$179K ﹤0.01% 3175

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Dimensional Fund Advisors's THRD Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 93,939 shares — an estimated $505K sold.

Dimensional Fund Advisors first reported a position in THRD in Q2 2024 and held it in 6 quarters. The position peaked at $733K in Q4 2024. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 93,939 Third Harmonic Bio shares in Q4 2025, an estimated $505K.
  • Dimensional Fund Advisors first reported a position in Third Harmonic Bio in Q2 2024 and held it in 6 quarters.
  • Dimensional Fund Advisors's Third Harmonic Bio position peaked at $733K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.